Contract Service Directory

Valsynthese AG





Company Headquarters

Fabrikstrasse 48
Brig, 3900
Switzerland

Company Description

Valsynthese offers custom synthesis and contract manufacturing of chemical intermediates and APIs. The company provides customers with complete solutions from process development to industrial production and from preclinical to commercial quantities. Services include full regulatory support from process validation, stability testing to preparation of documents, such as CMC document and Drug Master File, required for registration. Valsynthese is committed to ever greater levels of achievement in environmental and safety, as well as quality and regulatory compliance excellence.

Contract Service Directory

    Related Content

    • Process Development for Scaled-up hESC/hiPSC Manufacturing

      An optimized 14-day manufacturing workflow which produces > 10^10 , cells was developed in < 12 months

    • Breaking News | CRO News | Facilities | Industry News
      CatSci Expands Capabilities with Lab Expansion

      CatSci Expands Capabilities with Lab Expansion

      Continuing strategic growth.
      CatSci 12.11.19

    • Breaking News | Collaborations & Alliances | Drug Discovery
      IONTAS, Adaptate Enter Antibodies Alliance

      IONTAS, Adaptate Enter Antibodies Alliance

      To generate and optimize antibodies for novel immuno-oncology targets
      12.03.19


    • Bio News | Bioanalytical Services | Breaking News | Facilities | Industry News
      Horizon Therapeutics Expands Capabilities

      Horizon Therapeutics Expands Capabilities

      Opens new manufacturing and R&D facility in South San Francisco.
      11.26.19

    • Bio News | Breaking News | Industry News
      Entera Bio Establishes U.S. HQ in Wellesley, MA

      Entera Bio Establishes U.S. HQ in Wellesley, MA

      Jonathan Lieber will serve as the company's U.S.-based chief financial officer
      11.21.19

    • CPL

      CPL's David Tyler

      CPL's director of business development was on hand at Contract Pharma 2019.
      Contract Pharma


    • Biologics, Proteins, Vaccines | cGMP Manufacture | Drug Development | Industry News
      Takeda to Open New Plant in Germany

      Takeda to Open New Plant in Germany

      Will manufacture the company's dengue vaccine candidate TAK-003
      11.08.19

    • Valsynthese

      Valsynthese

      Custom manufacturer with focus on development and synthesis under GMP and ISO 9001 environment.
      10.24.19

    • cGMP Manufacture
      Deriving Value from Integrated cGMP and Pre-GMP Manufacturing Operations

      Deriving Value from Integrated cGMP and Pre-GMP Manufacturing Operations

      The benefits of leveraging a mix of GMP and pre-GMP facilities.
      Didier Combis, Commercial Director, Seqens CDMO 10.15.19


    • APIs | Cytotoxics and High Potency Manufacturing | Facilities
      Flamma Arrives in the U.S.

      Flamma Arrives in the U.S.

      Italian CDMO sets down roots in the U.S. market with purchase of Teva facility.
      Tim Wright, Editor, Contract Pharma 10.15.19

    • Breaking News | cGMP Manufacture | Chemistry | Drug Development | Industry News
      CMAB Biopharma, BJ Bioscience in Strategic Development and Mfg. Pact

      CMAB Biopharma, BJ Bioscience in Strategic Development and Mfg. Pact

      CMAB will provide a full range of CMC research and manufacturing services to support IND applications for China and the U.S.
      10.11.19

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
      Prevail, Lonza Enter Development and Mfg. Alliance

      Prevail, Lonza Enter Development and Mfg. Alliance

      Lonza will manufacture Prevail's AAV-based gene therapy programs for neurodegenerative diseases
      10.08.19


    • Industry News | Process Development
      Cambrex Expands Process Development at Edinburgh Facility

      Cambrex Expands Process Development at Edinburgh Facility

      Doubles current footprint to 15,000 sq. ft., adding lab space to accommodate 40 more scientists
      07.30.19

    • Promotions & Moves
      Mereo BioPharma Appoints Head of Pharma Development

      Mereo BioPharma Appoints Head of Pharma Development

      Richard Francis brings more than 35 years of experience in biopharmaceutical process development and manufacturing operations
      07.16.19